Table 2.
PND | Control (n = 16) | NEC (n = 23) | NEC + PBS (n = 15) | NEC + hBM-MSCs 0.5 × 106 (n = 23) | NEC + hBM-MSCs 1 × 106 (n = 15) |
---|---|---|---|---|---|
2 | 1.55 (0.04) | 1.54 (0.04) | 1.66 (0.05) | 1.66 (0.02) | 1.66 (0.06) |
3 | 1.82 (0.06) | 1.81 (0.04) | 2.07 (0.06) * | 2.03 (0.04) * | 1.92 (0.09) |
4 | 2.13 (0.09) | 1.79 (0.05) *** | 1.92 (0.05) | 1.93 (0.05) | 1.95 (0.09) |
5 | 2.65 (0.09) | 1.77 (0.05) *** | 1.79 (0.05) *** | 1.81 (0.05) *** | 1.86 (0.08) *** |
6 | 3.16 (0.09) | 1.69 (0.05) *** | 1.75 (0.06) *** | 1.85 (0.08) *** | 1.74 (0.06) *** |
g: grams; hBM-MSC: human bone marrow-derived mesenchymal stromal cells; n: number of pups; NEC: necrotizing enterocolitis; PBS: phosphate-buffered saline; PND: postnatal days. Variables are expressed as mean (SEM); * p < 0.05 vs. control; *** p < 0.001 vs. control. Two-way ANOVA with Sidak multiple comparisons post-hoc test.